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SUMMARY
A 26- year- old man, returned to the UK having travelled 
extensively in Asia. He was referred with a 3- month 
history of distal leg ulceration following an insect bite 
while in Thailand. Despite multiple courses of oral 
antibiotics, he developed two adjacent ulcers. A wound 
swab isolated an organism identified as Burkholderia 
thailandensis. The histology of the skin biopsy was 
non- specific. A diagnosis of cutaneous melioidosis was 
made, based on clinical and microbiological grounds. 
The ulcers re- epithelialised on completion of intravenous 
ceftazidime followed by 3 months of high dose co- 
trimoxazole and wound care. Many clinical microbiology 
laboratories have limited diagnostics for security- related 
organisms, with the result that B. pseudomallei, the 
causative bacterium of melioidosis, may be misidentified. 
This case highlights the importance of maintaining high 
levels of clinical suspicion and close microbiological 
liaison in individuals returning from South- East Asia and 
northern Australia with such symptoms.
BACKGROUND
Melioidosis is an infection caused by Burkholderia 
pseudomallei, an environmental Gram‐negative 
bacillus endemic in the tropics and subtropics, 
most commonly reported in northern Australia 
and Southeast Asia.1 Acquisition is via exposure to 
contaminated soil or surface freshwater, with trans-
mission primarily by implantation or inhalation. 
A significant cause of morbidity and mortality in 
these regions, infection may be localised or dissem-
inated and presentations vary from acutely fulmi-
nant to chronically indolent. Pneumonia occurs in 
about 50% of cases, often accompanied by bacte-
raemia and septic shock with mortality rates of 
10%–20%. Important risk factors for severe disease 
are diabetes, excessive alcohol use, chronic renal 
and chronic lung disease but it may occur, uncom-
monly, in healthy individuals. Approximately 20% 
of individuals present with cutaneous melioidosis 
(CM), mostly with chronic ulcers and abscesses but 
CM can also be complicated by necrotising fasciitis, 
osteomyelitis and sepsis.2 3 In non- endemic areas, 
melioidosis poses a diagnostic challenge due to its 
ability to mimic other diseases including pulmonary 
tuberculosis.
This case report describes a case of CM, where 
the presenting complaint was non- healing leg 
ulceration.
CASE PRESENTATION
A 26- year- old man who returned to the UK having 
travelled extensively in Asia was referred to our 
dermatology service with a 3- month history of 
distal left leg ulceration. He reported a lesion on 
the lateral left lower leg just proximal to the lateral 
malleolus, which he attributed to an insect bite 
while in Thailand. Initially, the lesion was erythem-
atous, enlarged and subsequently ulcerated. The 
lesion was debrided in Nepal and then again in 
India. There was no improvement and despite 
multiple courses of oral antibiotics, he developed 
two more ulcers, on the anterior and medial lower 
leg, adjacent to the original ulcer (figure 1). The 
edges of the ulcers were undermined which raised 
the clinical suspicion of pyoderma gangrenosum. 
The patient was systemically well with no evidence 
of fever, lymphadenopathy or organ dysfunction.
INVESTIGATIONS
A full blood count, urea and electrolytes, ESR and 
CRP were normal. Serology tests for HIV, Schisto-
soma, Strongyloides, Mycoplasma and Leishmania 
were negative. He had a weakly positive antinuclear 
antibody (1:80 nucleolar) and a negative double- 
stranded DNA.
An MRI scan of the left leg did not demonstrate 
evidence of tendinopathy or osteomyelitis.
An incisional skin biopsy was taken and the 
histology demonstrated ulceration and an acanthotic 
epithelium, overlying a deep dermal inflammatory 
infiltrate comprising of neutrophils, lymphocytes, 
histiocytes and plasma cells (figure 2). There was 
no evidence of granulomas, vasculitis, malig-
nancy or viral inclusions. Gram, DPAS, Grocott, 
Giemsa, Ziehl- Neelson and Wade- Fite special stains 
were all negative. The histological features were 
non- specific. Tissue bacterial and fungal cultures 
produced no significant growth, and Lesihmania 
PCR was negative.
After multiple wound swabs did not isolate a 
pathogen, one taken at the referring hospital grew 
an organism, which was identified as Burkholderia 
thailandensis.
A diagnosis of CM was made, based on clin-
ical and microbiological grounds. The causative 
organism for melioidosis is B. pseudomallei. The 
bacterial identification methodology identified B. 
thailandensis, a closely related but non- pathogenic 
relative; however, the organism’s unusual antibiotic 
susceptibility profile made B. pseudomallei a more 
likely culprit. Unfortunately, the isolate had been 
discarded and so further analysis was not possible.
DIFFERENTIAL DIAGNOSIS
The initial list of differential diagnoses for this case 
was wide given the non- specific presentation and 
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patient’s extensive travel through Southeast Asia. He had trav-
elled from Indonesia, the Philippines, Vietnam, Cambodia, Thai-
land, Nepal and India.
Infectious diseases were high on the list of differentials in this 
young fit man. Pathogens causing cutaneous ulceration most 
frequently include pyogenic bacteria such as Staphylococcus 
aureus and various beta- haemolytic streptococci. Mycobacterial 
infections may also produce cutaneous ulcers—Mycobacterium 
tuberculosis, M. ulcerans and non- tuberculous mycobacteria. 
Cutaneous leishmaniasis was considered, although clinical 
appearance and geographical exposure made this possibility 
unlikely. Fungal infections to consider include mycetoma, chro-
momycosis and sporotrichosis,4 typically after implantation inju-
ries. These were excluded with blood, tissue cultures and special 
stains on histology.
He had no risk factors for venous or arterial ulceration and 
there was no evidence of neuropathy. The undermined edges 
and violaceous surrounding tissue did raise the suspicion of 
pyoderma gangrenosum; however, neutrophils were not a prom-
inent feature on histology.
The skin biopsy did not demonstrate evidence of malignancy 
or vasculitis, important differentials in a patient with non- 
healing ulceration.
Figure 1 Clinical photographs of the ulcers prior to treatment with 
intravenous ceftazidime, oral co- trimoxazole and negative pressure 
dressings and after.
Figure 2 Incisional biopsy at low power with H&E staining 
demonstrating ulceration on the left, adjacent to an acanthotic 
epithelium with a dermal inflammatory infiltrate comprising of 
neutrophils, lymphocytes, histiocytes and plasma cells.
Patient’s perspective
“It all started in Thailand in December. I was staying at a hotel 
near a beach and noticed what I thought was an insect bite 
on my lower leg. It turned into a horrible black pustule which 
I squeezed and it formed a deep hole in my leg about 2 mm 
across. I carried on my travels and flew from Thailand to Nepal. I 
was very naive at this point and I didn’t know what an ulcer was. 
I even went on a 10- day hike in Nepal. However, around a month 
after, the ulcer had grown to around 10 mm across. I went to a 
doctor who gave me a minor debridement and some antibiotics. 
After a few months in Nepal, I carried on my travels to India 
where I got food poisoning. While I was unwell, I neglected to 
clean the wound with saline and change my bandages which I 
had been doing once a day. Then when I looked at it, the ulcer 
had a foul smell with a yellow discharge and it was surrounded 
by a blue ring. It looked like the skin around it was dead. I spoke 
to a surgeon in England who was a friend of the family. He told 
me I needed to get it debrided now. When I asked for the worse 
case scenario, he told me there was a possibilty of amputation. 
I was in a remote area in North India, so I travelled to a larger 
town, a day’s journey away. A surgeon agreed to debride the 
wound. This left an ulcer 35 mm in diameter and looked as if 
it was healing nicely. However, next to the original ulcer, the 
skin around it was irritated by the bandage and got infected. I 
then flew back to England in February and went to my GP who 
referred me to Dermatology at UCLH. Initially I was told it could 
possibly be pyoderma gangrenosum which freaked me out. I 
looked it up online and thought, this is something I am going to 
have to live with because it’s not a curable thing. At this point, 
the initial ulcer had started healing but two new ulcers had 
formed next to it, so I had three ulcers on my leg.
My practice nurse was cleaning the wound every 3 days and 
applying all sort of bandages, mainly aluminium based but it 
wasn’t improving. I was referred to a local wound care specialist 
who tried soaks and wipes with non- adherent gauze but the 
wounds didn’t change.
I went back to the GP for my results but all my blood tests 
were negative. No one knew what was going on. My whole leg 
had become swollen around the ulcers. Every morning I would 
lie in bed and I would dread getting up because every time I 
stood up, the blood would rush to the wounds and it was a 
sensation of knives stabbing me in the leg. It was absolutely 
agonising. I also had reduced mobility of my ankle so I couldn’t 
walk properly. It was probably the scariest time of my life. No 
one knew what was going on, I had expected once I got back 
to England it would heal but it was getting much worse and my 
mobility was decreasing.
After being in England for around 2 months, the nurse 
bandaging my leg collected some of the milky discharge which 
had started coming from the ulcer. That was the first sign of 
infection. The test showed this Burkholderia thailandensis. I 
was then admitted to a ward at my local hospital where I spent 
3 days in isolation on intravenous antibiotics. I had so many 
different types. I was re- referred to UCLH with the test result 
and was told it was very strange for B. thailandensis and it was 
likely Burkholderia pseudomallei but unfortunately the hospital 
didn’t save the sample. The doctors were then confident in what 
to do and the right type of antibiotics to treat me with. I had 
been on them for months and felt awful with stomach problems. 
I was put on intravenous antibiotics three times a day at my 
local acute medical unit which lasted for 4 weeks and then a 
Continued
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The possibility of melioidosis was discussed with the microbi-
ology department when a wound swab was reported as having 
isolated B. thailandensis.
TREATMENT
The patient had an initial course of antibiotics, followed by 
debridement at a hospital in India. On his return to the UK, 
he received multiple courses of antibiotics including amoxi-
cillin, flucloxacillin, clindamycin and co- amoxiclav with no 
improvement.
Intravenous ceftazidime three times a day with oral co- trimox-
azole (160 mg/800 mg) one tablet two times a day was started. 
Fucibet cream (a combined topical potent corticosteroid and 
fusidic acid), along with various wound dressings were used with 
no significant effect.
Once a diagnosis of CM was made, the dose of co- trimoxazole 
was increased to the recommended (160 mg/800 mg) two tablets 
two times a day with folic acid supplementation for 3 months. 
The topical corticosteroid was stopped. Our specialist derma-
tology nurse debrided and dressed the wound with a negative 
pressure dressing on a weekly basis for several weeks. The patient 
was then taught how to manage the negative pressure dressing.
OUTCOME AND FOLLOW-UP
Within 3 weeks of starting the higher dose of co- trimoxazole and 
negative pressure dressings, the ulcers re- epithelialised with scar-
ring (figure 1). There has been no recurrence of the skin lesions 
20 months after stopping oral co- trimoxazole.
DISCUSSION
Melioidosis is a challenging diagnosis to make. It is an important 
differential to consider in returning travellers with non- healing 
skin lesions or systemic illness. The prospective study and review 
of the literature carried out by Gibney et al3 demonstrated that 
the usual risk factors for systemic melioidosis of diabetes, alcohol 
excess and chronic renal and lung disease are often not present 
in individuals with CM. Investigations should include swabs to 
identify B. pseudomallei and should otherwise be guided by clin-
ical presentation. MRI is useful to exclude osteomyelitis If there 
is ulceration.
Due to the inherent resistance of B. pseudomallei to multiple 
antibiotics, the recommended treatment regimen of soft- tissue 
infection comprises of two phases: an initiation period with 
intravenous ceftazidime or meropenem and co- trimoxazole 
followed by an eradication phase with oral high- dose co- trimox-
azole for 3 months.5 The need for an intravenous stage in CM is 
uncertain, given reports of improvement in some cases with oral 
antibiotics alone.3
The diagnosis of melioidosis has traditionally relied on culture 
using selective media, biochemical tests and antibiograms that 
demonstrate intrinsic penicillin and aminoglycoside resistance. 
More recently however, laboratories have adopted matrix- 
assisted laser desorption/ionisation time- of- flight mass spectrom-
etry identification systems that examine bacterial cell proteins by 
their molecular weight and electronic charge. Species- specific 
signatures can be generated, allowing organisms to be iden-
tified by matching signatures to those in reference databases. 
However, many clinical microbiological laboratories do not have 
access to libraries that include security- related organisms, with 
the risk that any such organisms may be given alternative identi-
fications. Consequently, B. pseudomallei isolates have previously 
been reported as the non- pathogenic B. thailandensis.6 7 In the 
UK, Public Health England provides a species- specific molecular 
service for the diagnosis of melioidosis, and to date confirm that 
all isolates of B. thailandensis that have been submitted to them 
have in fact proven to be the closely related organism B. pseu-
domallei (D. Kenna, personal communication). This therefore 
emphasises that a high clinical suspicion is key to the diagnosis 
of CM.
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Patient’s perspective Continued
nurse came to my house for another 2 weeks. I wasn’t able to do 
anything else. I couldn’t really walk but luckily I could stay with 
my parents who supported me.
During this period, the amazing nurse in charge at the 
dermatology department of UCLH was treating my wound. She 
told me it was probably going to hurt and I was going to hate 
her for it. It was absolute agony but it really helped. She used 
a debriding pad and scrubbed the wound. I would see her once 
a week to change my dressing. I then had a special dressing 
with suction which she taught me how to use. That made such a 
difference to my wounds.
After about 6 months, the ulcers finally healed. It wasn’t until 
this time that I could walk normally and by August, so around 
8 months later, I could run without pain. I have some pretty 
strange scars with discoloured rings where the ulcers were but 
I’ve not had any problems since they healed. I managed to do a 
ski season which I have always wanted to do and I’ve gone back 
to work in construction. I now really appreciate my health.
The thing I was not prepared for was how it affected me 
mentally. It was really trying. I never considered how a physical 
illness can cause such a mental battle. Looking back, it makes 
me feel emotional. I am blessed to have had the support of my 
family and the NHS for all the care I had.”
Learning points
 ► Cutaneous melioidosis is an important differential diagnosis 
to consider in a returning traveller from Southeast Asia and 
northern Australia.
 ► Many UK laboratories may not have access to the extended 
database required to identify Burkholderia pseudomallei and 
so high clinical suspicion is needed and referral to a tertiary 
centre may be required.
 ► Optimal treatment for cutaneous melioidosis remains 
uncertain but may include intravenous therapy with 
ceftazidime or meropenem in addition to a prolonged oral 
course of co- trimoxazole.
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